The NICE Guideline On Medicinal Cannabis: Keeping Pandora's Box Shut Tight?

被引：25
作者：
Case, Paula [1 ]
机构：
[1] Univ Liverpool, Sch Law & Social Justice, Mulberry Court, Liverpool, Merseyside, England
来源：
MEDICAL LAW REVIEW | 2020年 / 28卷 / 02期
关键词：
Cannabis; Guideline; Legalisation; Medicines; NICE; Prescribing; PAIN;
D O I：
10.1093/medlaw/fwaa002
中图分类号：
D9 [法律]; DF [法律];
学科分类号：
0301 ;
摘要：
November 2018 saw the prescription of unlicensed medicinal cannabis products being legalised in the UK, accompanied by loud media fanfare. One year on, it seems that access to medicinal cannabis in this country continues to be extremely rare, raising questions about what might be stopping doctors from making use of the legal space to prescribe. This commentary explores some of these questions, outlining the theoretical space for legal prescribing and examining whether the recently announced National Institute for Health and Care Excellence guideline does anything to ease the deadlock.
引用
收藏
页码：401 / 411
页数：11
相关论文
共 33 条
[1]  
[Anonymous], 2019, HOSP TIMES APR
[2]  
[Anonymous], 2017, UN INT NARCOTICS CON
[3]  
[Anonymous], 2018, CANN BAS MED INT DES
[4]  
[Anonymous], 2018, GUID US CANN BAS PRO, P4
[5]  
[Anonymous], 2015, IMPORTING UNLICENSED
[6]  
[Anonymous], 2017, GUID US MED CANN TRE
[7]   Human rights, public health and medicinal cannabis use [J].
Bone, Melissa ;
Seddon, Toby .
CRITICAL PUBLIC HEALTH, 2016, 26 (01) :51-61
[8]  
Carrieri V, 1907 WP U YORK
[9]  
Cockburn T, 2019, LAW INNOVATION TECHN, V11, P46
[10]  
Davis Dame Sally, 2018, THERAPEUTIC MED BENE, P1
1234